Towards Healthcare
Insulin Drugs and Delivery Devices Market to Reach USD 49.18 Bn by 2034

Insulin Drugs and Delivery Devices Market Sees Strong 2025 Growth

According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of diabetes and growing research and development activities bolster market growth. North America led the global market owing to the presence of key players and favorable regulatory support.

  • Insight Code: 6146
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The insulin drugs and delivery devices market in 2025 is valued at USD 25.58 billion and is projected to climb to USD 49.18 billion by 2034, with a CAGR of 7.65% over the forecast period.

The insulin drugs and delivery devices market includes five segments by product type, by source, by distribution channel, by application, and by region.

Some key players include Novo Nordisk, Eli Lilly and Company, and Medtronic.

Key trends include the growing research activities, technological advancements, and increasing investments.

Insulin is commonly administered through subcutaneous insulin injections using vials, syringes, pens, and pumps.

World Health Organization, International Diabetes Federation, Statisque Canada